Skip to main content
SI-BONE, Inc. logo

SI-BONE, Inc. — Investor Relations & Filings

Ticker · SIBN ISIN · US8257041090 LEI · 549300J8JGYVJJHV9C31 US Manufacturing
Filings indexed 705 across all filing types
Latest filing 2026-06-08 Regulatory Filings
Country US United States of America
Listing US SIBN

About SI-BONE, Inc.

https://si-bone.com/

SI-BONE, Inc. is a medical device company that develops solutions for musculoskeletal disorders of the sacropelvic anatomy. The company pioneered the minimally invasive surgical (MIS) treatment of sacroiliac (SI) joint dysfunction, a common cause of chronic lower back pain, with its proprietary iFuse Implant System. The iFuse system is designed for sacroiliac joint fusion and stabilization. SI-BONE has expanded its portfolio to address other sacropelvic conditions, including pelvic fractures and instability, utilizing technologies such as 3D-printed implants. The company focuses on advancing the diagnostic understanding and surgical treatment of these often under-diagnosed and under-treated orthopedic conditions.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 88% confidence The document is an SEC Form 8-K “Current Report” covering multiple standard items: entry into a material lease amendment (Item 1.01), creation of a financial obligation (Item 2.03), and submission of matters to a vote of security holders with voting results (Item 5.07). It is a general regulatory filing rather than a standalone vote-results notice or a report publication announcement. Therefore it falls under the “Regulatory Filings” (RNS) category.
2026-06-08 English
10-Q - SI-BONE, Inc. (0001459839) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-11 English
SCHEDULE 13G/A - SI-BONE, Inc. (0001459839) (Subject)
Major Shareholding Notification
2026-03-27 English
S-3ASR - SI-BONE, INC. (0001459839) (Filer)
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is a registration statement under the Securities Act of 1933. It is a prospectus for the offering of securities, describing the terms of securities to be offered, risk factors, use of proceeds, and other related information. This type of filing is related to capital raising activities and financing. It is not an annual report, earnings release, or any other financial report but a capital/financing update document. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed registration and offering information, confirming it is not merely an announcement or a short notice.
2026-02-24 English
10-K - SI-BONE, INC. (0001459839) (Filer)
Annual Report FY 2025
2026-02-24 English
8-K - SI-BONE, INC. (0001459839) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes: 1) Entry into a material definitive lease agreement, 2) Announcement of quarterly and annual financial results via a press release attached as an exhibit, and 3) Appointment of a new Chief Operating Officer. The document does not contain full financial statements or detailed financial analysis itself but references a press release for results and states the lease agreement will be filed with the 10-K. The document is a regulatory announcement of multiple material events rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories. Confidence is high given the clear identification as a Form 8-K and the nature of the content.
2026-02-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.